Open
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
At $1.28 per share, NUGS is trading at 1,160X revenues.
HIPH has had 8 huge reverse splits. The company is a serial reverse splitter. Last one was 1 share for 5000 shares. Monster equity dilution.
MedMen is a bubble boy.
I was reading HIPH’s PR linked below and did some checking on this HIPH deal announcement with GRBX. After doing some research on GRBX, do people know GRBX has $0 in revenue?
https://ih.advfn.com/stock-market/USOTC/american-premium-water-HIPH/stock-news/79209394/american-premium-water-corp-hiph-announces-agreem
GRBX’s revenues are $0.
Why has CBIS been hiding CBIS’s finanances from shareholders for 1 1/2 years?
HIPH is a common equity dilution pump & dumper.
HIPH is a serial reverse splitting common equity dilution scam. Just look at the serial reverse splitting at HIPH.
1 for 25 share reverse split on April 6, 1999
1 for 1000 share reverse split on March 31, 2003
1 for 20 share reverse split on July 27, 2004
1 for 1000 share reverse split on October 17, 2007
1 for 500 share reverse split on January 9, 2009
1 for 1000 share reverse split on February 21, 2014
1 for 1000 share reverse split on March 17, 2015
1 for 5000 share reverse split on July 12, 2017
HIPH is a reverse splitting common equity dilution scam.
Just based on the most recent 1 share for 5000 share reverse split..... if you took HIPH’s current shares outstanding (290,768,165) and reversed out just that one split, 290,768,165 shares x 5000 HIPH would have more than 1 trillion shares. 1,453,840,825,000 common shares to be exact. HIPH just prints common shares and sells them as fast as possible. There is an unlimited supply of HIPH common shares. Literally.
HIPH is a serial reverse splitter. If you hypothetically, backed out all of HIPH’s common share reverse splits, your calculator couldn’t add up that many common HIPH common shares because it would run out of digits. You would end up with like a decillion HIPH common shares.
The article is dated February 5, 2019. And there is no shortage of other news articles about the New York City ban on CBD food and drinks that can be referenced in Google. It’s new news.
New York City bans CBD food and drinks.
https://www.google.com/amp/s/www.wsj.com/amp/articles/nyc-cracks-down-on-businesses-selling-cbd-infused-food-and-drinks-11549403905
In the last 10 trading sessions, DIRV’s price per share went up in 1 trading session, remained unchanged in 1 trading session, and went down in 8 trading sessions.
Click on SGMD’s 1 year stock chart and you can see what the massive common equity dilution is doing to the price per share.
All people have is GRBX’s most recent 10-Q filing to go on. So, I guess people are gonna need to just wait and see if GRBX has revenues greater than $0 in its next filing. Because $0 in sales does not impress me. Especially when GRBX’s outstanding shares have increased by more than 1000% in the last year. Huge dilution. GRBX’s Common equity structure is broken given it’s dilution rate. GRBX’s 6 month stock chart illustrates the broken math of GRBX’s common equity model.
Ton’s of common equity dilution at SGMD. SGMD is a new share printing machine. Outstanding shares bloating fast.
I know APRU is authorized to issue up to 50 BILLION shares. That’s a lot of zero’s as in 50,000,000,000 authorized common shares. Don’t know the current common shares outstanding because Tony never updated shareholders on the total number like he promised. But when you get up to billions upon billions of common shares, the supply of shares are so plentiful, the shares are like confetti. And unfortunately Tony has gagged their transfer agent from disclosing the number of APRU shares outstanding. So, Tony should do what he promised and disclose it. Even a Tweet of the accurate and current outstanding common shares will do. Would take him a minute to accomplish. Because shareholders deserve to know.
1 1/2 years since CBIS has filed a financial disclosure. No 10-K, no 10-Q’s since September 2017. Why would a CEO hide the books from shareholders for 1 1/2 years?
CBIS OTC Caveat emptor
The PR you have referenced here is from September and at the time of this PR, Mr. Yu was urging patience because the audit was already past due. Now here we are 5 months later and there is still no audit, and no audit of Worldwide Staffing. It’s not like auditing General Motors. The fact that the World Staffing acquisition was done 10 months ago and a NUGS audit still isn’t done doesn’t make any sense. NUGS isn’t adding up.
Strange Tony never updated OTC Markets or shareholders on the current number of common shares outstanding. He had promised to update everyone on the current number outstanding and he never followed through.
Ton’s of pinkie companies in the CBD water game now. Seems like the hot pinkie pump these days as everyone trading in pinkieland is playing CBD drinks. Just like crypto coins was the hot spin a year or so ago. This CBD drink space is getting very very crowded with pink companies spinning it their CBD brands.
GRBX needs to keep issuing and selling new shares for capital because the company to date has generated $0 in actual business. That could change but GRBX hasn’t, according to its most recent Quarterly Report, generate any sales.
DIRV is just bleeding millions. For the first 9 months of 2018 DIRV’s Net Losses have increased to ($15,354,173). In the same period last year DIRV lost ($4,911,834) so Net Losses at DIRV have more than tripled.
DIRECTVIEW HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the Nine Months Ended
September 30,
2018 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (15,354,173 ) $ (4,911,834 )
https://www.otcmarkets.com/filing/html?id=13072171&guid=QyJtUWsxkC9QKth
Haven’t seen one penny of revenues yet. Zero. And if you check the bottom of page 1 on this link below, GRBX reported 14,445,363 common shares on November 14, 2017.
https://www.otcmarkets.com/filing/html?id=12386265&guid=QyJtU65Tb1Y7Kth
And if you check the bottom of page 1 on this link below, GRBX reported 158,890,363 common shares outstanding on November 20, 2018.
https://www.otcmarkets.com/filing/html?id=13076331&guid=QyJtU65Tb1Y7Kth
Over the last year, GRBX’s outstanding share count has increased more than 10 fold. Examining GRBX’s equity model and common equity dilution at GRBX is amazing. Common equity structure has been sliced by 10X and peeps don’t even know it yet.
GRBX has no revenue. Arttached below is GRBX’s most recent 10-Q filing and you can read yourself if you don’t believe me. GRBX hasn’t yet generated any revenue. Revenues are $0.
https://www.otcmarkets.com/filing/html?id=13076331&guid=VoJtUHuCxwzHMth
Why does GRBX have a $36 million dollar valuation when the company has revenues of $0?
I was reading Ryan’s PR about the deal with Green Box GRBX.
https://finance.yahoo.com/news/american-premium-water-corp-hiph-123000995.html
Funny thing is when you check out GRBX, they’ve got revenues of $0. (See Link)
https://www.otcmarkets.com/filing/html?id=13076331&guid=VoJtUHuCxwzHMth
Company referred to as Green Box POS, LLC. What do you suppose the POS means in the name? Maybe they should call it Empty Box POS LLC?
I would never buy stock in CELZ. I’ve been reading all the past pumps going back here a way. Looking at CELZ 2 year stock chart and chuckle because CELZ does have funny 2 year stock performance. No, I’m here strictly for the entertainment, laughs & giggles.
Retail penny players are the only people remaining who have investment criteria low enough to invest in CELZ.
Why hasn’t Ray Dabney filed financials for almost 1 1/2 years? Major accounting irregularities at CBIS.
I’m blown away at the shear number of penny companies touting their CBD water/juices/teas etc.. Seems like now, every other pinkie company is touting their CBD drinks. I know legalization issues have a lot of people excited in potential opportunities for profit. But this CBD drink business is getting really really crowded as everyone is jumping on CBD water/drink business. I know HIPH has been touting their CBD water but it seems like there is a ridiculous amount of other companies doing the exact same thing. Seems everyone is in it vlaiming to be in the CBD drink biz.
CBIS hasn’t filed a financial disclosure since September 2017 quarter. No 10-K despite the NT. No 10-Q’s either. CBIS has been dark now going on 1 1/2 years. OTC’s has had the warning up for some time now as well. Ray is running out of time and the SEC clock has begun ticking.
Business seems very slow at DIRV. Think DIRV’s 4th Quarter was very slow too because there wasn’t a whole lot there in terms of much contract news. Also think 4th Quarter might be the slowest Quarter of the year. Not much in the way of any news this year and it appears DIRV’s Revenues have been dropping pretty fast since revenues peaked in the 3rd Quarter of 2017.
In Q3 of 2017 DIRV reached peak revenues of $1,369,885 for the Quarter.
Since Q3 of 2017 you’ve had a trend reversal in revenues. DIRV’s Quarterly revenues are now in a clear downtrend as shown below.
In Q1 of 2018 DIRV reported revenues of $1,201,130.
In Q2 of 2018 DIRV reported revenues of $1,110,648.
In Q3 of 2018 DIRV reported revenues of $1,007,416.
If you examine revenue trends since Q3 of 2017 it’s clear that revenues have been dropping every subsequent Quarter since Q3 of 2017 and it’s likely given the trends, DIRV will report less than $1,000,000 revenues for Q4 2018.
For the first 3 Quarters of the the year, DIRV’s sales total $3,319,194. Obviously there is still DIRV’s 4th Quarter Revenues to added to arrive at full year revenue results but it appears that DIRV will badly miss Roger’s revenue forecasts.
As you can read in this DIRV PR, Roger was touting the acquisitions of Virtual Surveillance/Apex CCTV statinghad 2016 revenues of $5,300,000.
If DIRV has done $3,319,194 through the first 3 Quarters of 2018, its looking like DIRV’s full year revenue will be significant less than $5,300,000 in revenues mention in the linked PR below. And this revenue estimate was for Virtual Surveillance/Apex CCTV alone, and a 2016 revenue estimate.
https://www.prnewswire.com/news-releases/directview-completes-acquisition-of-two-privately-held-texas-based-security-and-surveillance-companies-with-combined-fiscal-2016-revenue-of-approximately-53-million-620587223.html
So when you read the PR touting $5.3 million in VS/Apex revenues, clearly DIRV will report full year 2018 revenues way below Roger’s previous revenue projections. Additionally, not only do revenues look well below management’s previous revenue forecasts, but as outlined at the top of my post, revenue results keep trending lower and lower every quarter while net losses are going through the roof
The DIRV/VS/Apex combination has been losing revenues and losing a lot more money ever since Roger took control of VS/Apex. The negative results are clear.
Bouncing on the PR. However, what people don’t realize is that Net Losses are accelerating rapidly at SGMD.
In 2017 SGMD posted a Net Loss of ($4,713,697)......losing on average $1,178,424 per Quarter.
In 2018 SGMD posted a Net Loss of ($6,296,390)......losing on average $1,574,097 per Quarter.
And in the most recent Quarter SGMD posted a Net Loss of $2,609,053. If the most recent Quarterly Loss is any indicator, SGMD is on track to lose more than $10,000,000 this year.
SGMD cash burn is increasing fast.
My point is that there is a record amount of cash on corporate balance balance sheets and no shortage of companies looking to acquire stakes in intellectual property that could prove lucrative in the future. Naturally if a stake in intellectual property with excellent future potential could be purchased, and purchased for a lot less than it would have cost to acquire a couple years ago, the intellectual property would have potential acquirers taking stakes already. And you look at CELZ 2 year stock chart and wonder if Caverstem had potential for big profits, why hasn’t any other public or private equity company purchased a minority stake in CELZ? When experts in health care aren’t buying CELZ at these levels, the only players left are the capital source of last resort........retail penny players.
Click on CELZ’s 2 year stock chart and ask this question.......1)If Caverstem had any real merit, why does CELZ’s 2 year stock chart look the way it does? And 2) since CELZ’s stock price has gone from point A (2 years ago) to point B ( price per share today), one should ask this question.....3)Despite the huge drop in CELZ shares over the past 2 years, why hasn’t any other company on the planet purchased CELZ shares, even at today’s price per share, that is much much less than CELZ’s price per share was 2 years ago? When industry insiders and experts aren’t interested in buying CELZ shares at any price, the marketplace is telling you that retail penny players are the last resort, and only resort as a source for capital. If Caverstem had any real profit growth potential, it’s 2 year stock chart would not depict the disaster that is self evident in the 2 year chart.
I clicked on CELZ 6 month stock chart. Gosh that’s ugly. My condolences to any longs holding CELZ the last 6 months. I guess if people still hold it they’re praying for divine intervention.
Dilution on the HIPH common is beginning to get discounted into the PPS as the outstanding common share count is becoming bloated at too fast a rate. Serial mass dilution.
CBIS dropped today because CBIS hasn’t filed a single Quarterly Report since September 30, 2017......or nearly 1 1/2 years with zero financial disclosure. When a public company goes dark on its financials, and remains dark 1 1/2 years later, something is seriously amiss.
Here’s the problem with that thesis. SGMD is losing a lot of money and now they’re losing a lot more money faster. And if one compares SGMD’s net losses in 2018 compared to SGMD’s net losses in 2017, one can notice that SGMD’s net losses have increased approximately 160% since last year. And if one examines SGMD’s net losses in it’s most recent Quarter it’s obvious that losses are accelerating at an even faster rate.
Nope. There must be a reason NUGS won’t disclose the results of the audit. The results must have been known by management but management decided for whatever reason, not to disclose it to shareholders. NUGS isn’t adding up.